Epinephrine and High-Flow Reperfusion After Cardiac Arrest in a Canine Model

Mark G. Angelos, Daniel J. DeBehnke

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Study objectives: Epinephrine has been used in cardiac arrest to increase the low blood flow generated by standard CPR methods. Reperfusion with high flow such as that obtained with cardiopulmonary bypass (CPB) may obviate the need for or alter the dose of epinephrine after cardiac arrest. The objective of this study was to evaluate the effect of high-flow reperfusion after cardiac arrest with and without epinephrine on coronary perfusion pressure, defibrillation energy, restoration of spontaneous circulation (ROSC), and 2-hour survival after prolonged cardiac arrest. Design: Prospective, randomized, double-blind, placebo-controlled study using a canine model. Interventions: Thirty mongrel dogs were randomized to receive, after ventricular fibrillation cardiac arrest of 12 minutes' duration without CPR, placebo (n=10), standard-dose epinephrine (.02 mg/kg) (n=10), or high-dose epinephrine (.2 mg/kg) (n=10) during reperfusion with CPB. Epinephrine or placebo was given with the start of CPB and then every 5 minutes, followed by countershock until ROSC or crossover at the fourth dose to high-dose epinephrine. Results: ROSC was achieved in the first 15 minutes of bypass in 10 of 10 dogs given high-dose epinephrine, in 9 of 10 given standard-dose epinephrine, and in 1 of 10 given placebo. After the crossover to high-dose epinephrine, ROSC was achieved in 8 of 10 dogs originally given placebo and the remaining animal given the standard dose of epinephrine. During early reperfusion, the high-dose group had a higher mean coronary perfusion pressure (high dose, 153+62 mm Hg; standard dose, 81±18 mm Hg; placebo, 51±15 mm Hg; P<.002) and a shorter mean ROSC time (high dose, 16.2±.8 minutes; standard dose, 20.3±3.6 minutes; placebo, 27.9±3.2; P<.02) and required less defibrillation energy. CPB flow during ventricular fibrillation was 63% of baseline cardiac output in all three groups. Two-hour survival was 5 of 10 in the high-dose group, 8 of 10 in the standard-dose group, and 5 of 10 in the placebo group. Conclusion: Restoration of high blood flow alone is insufficient to restore spontaneous circulation after prolonged cardiac arrest. Epinephrine, when administered early under high-flow conditions, increases coronary perfusion pressure, decreases defibrillation energy, and decreases time elapsed before ROSC. Higher doses of epinephrine under conditions of high-flow reperfusion do not improve 2-hour survival compared with standard-dose epinephrine. [Angelos MG, DeBehnke DJ: Epinephrine and high-flow reperfusion after cardiac arrest in a canine model. Ann Emerg Med August 1995;26:208-215.].

Original languageEnglish (US)
Pages (from-to)208-215
Number of pages8
JournalAnnals of emergency medicine
Volume26
Issue number2
DOIs
StatePublished - Aug 1995

Fingerprint

Heart Arrest
Epinephrine
Reperfusion
Canidae
Placebos
Cardiopulmonary Bypass
Perfusion
Cardiopulmonary Resuscitation
Ventricular Fibrillation
Dogs
Pressure
Cardiac Output

ASJC Scopus subject areas

  • Emergency Medicine

Cite this

Epinephrine and High-Flow Reperfusion After Cardiac Arrest in a Canine Model. / Angelos, Mark G.; DeBehnke, Daniel J.

In: Annals of emergency medicine, Vol. 26, No. 2, 08.1995, p. 208-215.

Research output: Contribution to journalArticle

Angelos, Mark G. ; DeBehnke, Daniel J. / Epinephrine and High-Flow Reperfusion After Cardiac Arrest in a Canine Model. In: Annals of emergency medicine. 1995 ; Vol. 26, No. 2. pp. 208-215.
@article{0f8a1839dbce423390195b4beac22016,
title = "Epinephrine and High-Flow Reperfusion After Cardiac Arrest in a Canine Model",
abstract = "Study objectives: Epinephrine has been used in cardiac arrest to increase the low blood flow generated by standard CPR methods. Reperfusion with high flow such as that obtained with cardiopulmonary bypass (CPB) may obviate the need for or alter the dose of epinephrine after cardiac arrest. The objective of this study was to evaluate the effect of high-flow reperfusion after cardiac arrest with and without epinephrine on coronary perfusion pressure, defibrillation energy, restoration of spontaneous circulation (ROSC), and 2-hour survival after prolonged cardiac arrest. Design: Prospective, randomized, double-blind, placebo-controlled study using a canine model. Interventions: Thirty mongrel dogs were randomized to receive, after ventricular fibrillation cardiac arrest of 12 minutes' duration without CPR, placebo (n=10), standard-dose epinephrine (.02 mg/kg) (n=10), or high-dose epinephrine (.2 mg/kg) (n=10) during reperfusion with CPB. Epinephrine or placebo was given with the start of CPB and then every 5 minutes, followed by countershock until ROSC or crossover at the fourth dose to high-dose epinephrine. Results: ROSC was achieved in the first 15 minutes of bypass in 10 of 10 dogs given high-dose epinephrine, in 9 of 10 given standard-dose epinephrine, and in 1 of 10 given placebo. After the crossover to high-dose epinephrine, ROSC was achieved in 8 of 10 dogs originally given placebo and the remaining animal given the standard dose of epinephrine. During early reperfusion, the high-dose group had a higher mean coronary perfusion pressure (high dose, 153+62 mm Hg; standard dose, 81±18 mm Hg; placebo, 51±15 mm Hg; P<.002) and a shorter mean ROSC time (high dose, 16.2±.8 minutes; standard dose, 20.3±3.6 minutes; placebo, 27.9±3.2; P<.02) and required less defibrillation energy. CPB flow during ventricular fibrillation was 63{\%} of baseline cardiac output in all three groups. Two-hour survival was 5 of 10 in the high-dose group, 8 of 10 in the standard-dose group, and 5 of 10 in the placebo group. Conclusion: Restoration of high blood flow alone is insufficient to restore spontaneous circulation after prolonged cardiac arrest. Epinephrine, when administered early under high-flow conditions, increases coronary perfusion pressure, decreases defibrillation energy, and decreases time elapsed before ROSC. Higher doses of epinephrine under conditions of high-flow reperfusion do not improve 2-hour survival compared with standard-dose epinephrine. [Angelos MG, DeBehnke DJ: Epinephrine and high-flow reperfusion after cardiac arrest in a canine model. Ann Emerg Med August 1995;26:208-215.].",
author = "Angelos, {Mark G.} and DeBehnke, {Daniel J.}",
year = "1995",
month = "8",
doi = "10.1016/S0196-0644(95)70153-2",
language = "English (US)",
volume = "26",
pages = "208--215",
journal = "Annals of Emergency Medicine",
issn = "0196-0644",
publisher = "Mosby Inc.",
number = "2",

}

TY - JOUR

T1 - Epinephrine and High-Flow Reperfusion After Cardiac Arrest in a Canine Model

AU - Angelos, Mark G.

AU - DeBehnke, Daniel J.

PY - 1995/8

Y1 - 1995/8

N2 - Study objectives: Epinephrine has been used in cardiac arrest to increase the low blood flow generated by standard CPR methods. Reperfusion with high flow such as that obtained with cardiopulmonary bypass (CPB) may obviate the need for or alter the dose of epinephrine after cardiac arrest. The objective of this study was to evaluate the effect of high-flow reperfusion after cardiac arrest with and without epinephrine on coronary perfusion pressure, defibrillation energy, restoration of spontaneous circulation (ROSC), and 2-hour survival after prolonged cardiac arrest. Design: Prospective, randomized, double-blind, placebo-controlled study using a canine model. Interventions: Thirty mongrel dogs were randomized to receive, after ventricular fibrillation cardiac arrest of 12 minutes' duration without CPR, placebo (n=10), standard-dose epinephrine (.02 mg/kg) (n=10), or high-dose epinephrine (.2 mg/kg) (n=10) during reperfusion with CPB. Epinephrine or placebo was given with the start of CPB and then every 5 minutes, followed by countershock until ROSC or crossover at the fourth dose to high-dose epinephrine. Results: ROSC was achieved in the first 15 minutes of bypass in 10 of 10 dogs given high-dose epinephrine, in 9 of 10 given standard-dose epinephrine, and in 1 of 10 given placebo. After the crossover to high-dose epinephrine, ROSC was achieved in 8 of 10 dogs originally given placebo and the remaining animal given the standard dose of epinephrine. During early reperfusion, the high-dose group had a higher mean coronary perfusion pressure (high dose, 153+62 mm Hg; standard dose, 81±18 mm Hg; placebo, 51±15 mm Hg; P<.002) and a shorter mean ROSC time (high dose, 16.2±.8 minutes; standard dose, 20.3±3.6 minutes; placebo, 27.9±3.2; P<.02) and required less defibrillation energy. CPB flow during ventricular fibrillation was 63% of baseline cardiac output in all three groups. Two-hour survival was 5 of 10 in the high-dose group, 8 of 10 in the standard-dose group, and 5 of 10 in the placebo group. Conclusion: Restoration of high blood flow alone is insufficient to restore spontaneous circulation after prolonged cardiac arrest. Epinephrine, when administered early under high-flow conditions, increases coronary perfusion pressure, decreases defibrillation energy, and decreases time elapsed before ROSC. Higher doses of epinephrine under conditions of high-flow reperfusion do not improve 2-hour survival compared with standard-dose epinephrine. [Angelos MG, DeBehnke DJ: Epinephrine and high-flow reperfusion after cardiac arrest in a canine model. Ann Emerg Med August 1995;26:208-215.].

AB - Study objectives: Epinephrine has been used in cardiac arrest to increase the low blood flow generated by standard CPR methods. Reperfusion with high flow such as that obtained with cardiopulmonary bypass (CPB) may obviate the need for or alter the dose of epinephrine after cardiac arrest. The objective of this study was to evaluate the effect of high-flow reperfusion after cardiac arrest with and without epinephrine on coronary perfusion pressure, defibrillation energy, restoration of spontaneous circulation (ROSC), and 2-hour survival after prolonged cardiac arrest. Design: Prospective, randomized, double-blind, placebo-controlled study using a canine model. Interventions: Thirty mongrel dogs were randomized to receive, after ventricular fibrillation cardiac arrest of 12 minutes' duration without CPR, placebo (n=10), standard-dose epinephrine (.02 mg/kg) (n=10), or high-dose epinephrine (.2 mg/kg) (n=10) during reperfusion with CPB. Epinephrine or placebo was given with the start of CPB and then every 5 minutes, followed by countershock until ROSC or crossover at the fourth dose to high-dose epinephrine. Results: ROSC was achieved in the first 15 minutes of bypass in 10 of 10 dogs given high-dose epinephrine, in 9 of 10 given standard-dose epinephrine, and in 1 of 10 given placebo. After the crossover to high-dose epinephrine, ROSC was achieved in 8 of 10 dogs originally given placebo and the remaining animal given the standard dose of epinephrine. During early reperfusion, the high-dose group had a higher mean coronary perfusion pressure (high dose, 153+62 mm Hg; standard dose, 81±18 mm Hg; placebo, 51±15 mm Hg; P<.002) and a shorter mean ROSC time (high dose, 16.2±.8 minutes; standard dose, 20.3±3.6 minutes; placebo, 27.9±3.2; P<.02) and required less defibrillation energy. CPB flow during ventricular fibrillation was 63% of baseline cardiac output in all three groups. Two-hour survival was 5 of 10 in the high-dose group, 8 of 10 in the standard-dose group, and 5 of 10 in the placebo group. Conclusion: Restoration of high blood flow alone is insufficient to restore spontaneous circulation after prolonged cardiac arrest. Epinephrine, when administered early under high-flow conditions, increases coronary perfusion pressure, decreases defibrillation energy, and decreases time elapsed before ROSC. Higher doses of epinephrine under conditions of high-flow reperfusion do not improve 2-hour survival compared with standard-dose epinephrine. [Angelos MG, DeBehnke DJ: Epinephrine and high-flow reperfusion after cardiac arrest in a canine model. Ann Emerg Med August 1995;26:208-215.].

UR - http://www.scopus.com/inward/record.url?scp=0029157812&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029157812&partnerID=8YFLogxK

U2 - 10.1016/S0196-0644(95)70153-2

DO - 10.1016/S0196-0644(95)70153-2

M3 - Article

C2 - 7618785

AN - SCOPUS:0029157812

VL - 26

SP - 208

EP - 215

JO - Annals of Emergency Medicine

JF - Annals of Emergency Medicine

SN - 0196-0644

IS - 2

ER -